FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LITHOBID (lithium carbonate) by ANI Pharmaceuticals, Inc. under NDA 018027. The action represents an approved supple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithobid (lithium carbonate)

Snippet

SUPPL AP for LITHOBID (LITHIUM CARBONATE)